Amengual O, Atsumi T.
COVID-19 pandemic in Japan.
Rheumatology International. Accepted, October 29, 2020. In press DOI:
10.1007/s00296-020-04744-9
IF: 1.984
Suzuki K, Suda G, Yamamoto Y, Furuya K, Baba M, Nakamura A, Miyoshi H, Kimura M, Maehara O, Yamada R, Kitagataya T, Yamamoto K, Shigesawa T, Nakamura A, Ohara M, Kawagishi N, Nakai M, Sho T, Natsuizaka M, Morikawa K, Ogawa K, Ohnishi S and Sakamoto N for the NORTE Study Group.
Tenofovir disoproxil fumarate modulates lipid metabolism via hepatic CD36/PPAR-alpha activation in hepatitis B virus infection. J Gastroenterol, in press.
IF: 6.132
Favorable effect of sodium‐glucose co‐transporter‐2 inhibitor dapagliflozin on nonalcoholic fatty liver disease compared with pioglitazone.
Cho KY, Nakamura A, Omori K, Takase T, Miya A, Yamamoto K, Nomoto H, Kameda H, Taneda S, Kurihara Y, Aoki S, Atsumi T, Miyoshi H Journal of Diabetes Investigation, in press.
IF 3.761
Khatri S,Psaraftis N, Funaro A, Arinuma Y, Fujieda Y, Mader, S,Jørgensen CD and AstakhovaK.
Serological Comparison of Systemic Lupus Erythematosus with Neuropsychiatric Lupus using Synthetic Nucleic Acid Antigens Journal of Translational Autoimmunity
IF：なし
Miyoshi A, Kameda H, Nagai S, Nakamura A, Miya A, Takase T, Astumi T, Miyoshi H.
Beneficial effects of switching to denosumab from bisphosphonates or selective estrogen receptor modulator in postmenopausal women with type 2 diabetes and osteoporosis.
Journal of Diabetes Investigation, in press.
IF: 3.761
Klionsky DJ,,, Kato M,,, et al. (2345 coauthors) Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition).
Autophagy, in press.
IF：9.770
Naruse K, Abiko A, Nakayama H, Tanaka N, Ikeda K, Imachi H, Usigome E, Umayahara Y, Ota S, Okada Y, Kodani N, Takahashi N, Terai A, Nakamura A, Fujikawa R, Miura J, Morita E, Yanagimachi M, Ueki K on behalf of the Japan Diabetes Society Committee to Promote Female Diabetologists.
The work style and living condition survey of diabetologists and the expectations for the Japan Diabetes Society: results of questionnaires about the current state and the future prospect of their carrier in 2017.
Diabetol Int. 11:299–308, 2020
IF:なし
Aika Miya, Akinobu Nakamura, Takahisa Handa, Hiroshi Nomoto, Hiraku Kameda, Kyu Yong Cho, So Nagai, Hideaki Miyoshi, Tatsuya Atsumi Impaired insulin secretion predicting unstable glycemic variability and Time-Below-Range in type 2 diabetes regardless of HbA1c or diabetes treatment Journal of Diabetes Investigation, in press.
IF: 3.761
Kato M, Sugimoto A, Atsumi T. Diagnostic and prognostic markers and treatment of connective tissue disease-associated pulmonary arterial
hypertension: current recommendations and recent advances. Expert Review of Clinical Immunology, in press.
IF: 3.792
